identifier,alternative_identifiers,country,continent,region,culture,epoch,group,comment,latitude,longitude,sex,site,site_detail,mt_hg,ychr_hg,year_from,year_to,date_detail,bp,c14_lab_code,reference_name,reference_linkd,data_link,c14_sample_tag,c14_layer_tag,ychr_snps,avg_coverage,sequence_source,mitopatho_alleles,mitopatho_positions,mitopatho_locus,mitopatho_diseases,mitopatho_statuses,mitopatho_homoplasms,mitopatho_heteroplasms
I1415,I1415_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,-8790,-8690,"8176-7608 calBCE (8790±50 BP, Poz-81101)",8790,nan,Lazaridis et al. 2022,,,0,0,..,23.444746,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1701,I1701_enhanced,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,F,'Ain Ghazal,,K1a18,n/a (female),-8620,-8520,"7752-7543 calBCE (8620±50 BP, Poz-81094)",8620,nan,Lazaridis et al. 2022,,,0,0,n/a (female),14.818215,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1707,I1707,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,R0a,..,-8590,-8490,"7732-7537 calBCE (8590±50 BP, Poz-81097)",8590,nan,Lazaridis et al. 2016,,,0,0,..,20.3,fasta,,,,,,,
I1710,I1710,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,-8580,-8460,"7741-7522 calBCE (8580±60 BP, Poz-81098)",8580,nan,Lazaridis et al. 2016,,,0,0,..,48.5,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1704,I1704,Jordan,,,Jordan_PPNB_contam,,Jordan_PPNB_contam,,31.988,35.976,F,'Ain Ghazal,,T,n/a (female),-8190,-8070,"7451-7056 calBCE (8190±60 BP, Poz-81095)",8190,nan,Lazaridis et al. 2016,,,0,0,n/a (female),21.7,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1415,I1415,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,M,'Ain Ghazal,,T1a2,..,-8790,-8690,"8176-7608 calBCE (8790±50 BP, Poz-81101)",8790,nan,Lazaridis et al. 2016,,,0,0,..,10.035307,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I1701,I1701,Jordan,,,Jordan_PPNB,,Jordan_PPNB,,31.988,35.976,F,'Ain Ghazal,,K,n/a (female),-8620,-8520,"7752-7543 calBCE (8620±50 BP, Poz-81094)",8620,nan,Lazaridis et al. 2016,,,0,0,n/a (female),7.87718,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1409,I1409,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,F,Areni 1,,U4a,n/a (female),-5260,-5200,"4230-3984 calBCE (5260±30 BP, Poz-81110)",5260,nan,Lazaridis et al. 2016,,,0,0,n/a (female),22.2,fasta,11467G;12308G;12372A;15693C;195C;499A,11467;12308;12372;15693;195;499,MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possibly LVNC cardiomyopathy-associated;BD-associated / melanoma pts;Endometriosis,Reported,+,-;+
I1631,I1631,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,F,Areni 1,,K1a8,n/a (female),-5323,-5263,"4311-4049 calBCE (5323±30 BP, OxA-19332)",5323,nan,Lazaridis et al. 2016,,,0,0,n/a (female),468,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1632,I1632,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,M,Areni 1,,K,..,-5285,-5227,"4236-3994 calBCE (5285±29 BP, OxA-18599)",5285,nan,Lazaridis et al. 2016,,,0,0,..,267,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1634,I1634,Armenia,,,Armenia_C,,Armenia_C,,39.73,45.2,M,Areni 1,,H2a1,..,-5366,-5304,"4330-4056 calBCE (5366±31 BP, OxA-19331)",5366,nan,Lazaridis et al. 2016,,,0,0,..,482,fasta,,,,,,,
I1633,I1633,Armenia,,,Armenia_EBA,,Armenia_EBA,,40.65,45.1167,F,Kalavan,,H1u,n/a (female),-3990,-3920,"2621-2354 calBCE (3990±35 BP, Poz-22234)",3990,nan,Lazaridis et al. 2016,,,0,0,n/a (female),429,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I1635,I1635,Armenia,,,Armenia_EBA,,Armenia_EBA,,40.65,45.1167,M,Kalavan,,X2f,"R1b1x(R1b1a1, R1b1a2, R1b1c2, R1b1c3) ",-4005,-3935,"2623-2461 calBCE (4005±35 BP, Poz-81102)",4005,nan,Lazaridis et al. 2016,,,0,0,..,483,fasta,12705T;16189C;195C,12705;16189;195,MT-CO1;MT-CR,Possible protective factor for normal tension glaucoma;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts,Reported,NaN;+,NaN;-;+
I1658,I1658,Armenia,,,Armenia_EBA,,Armenia_EBA,,40.382958,43.873663,F,Talin,,U3a2a,n/a (female),-4492,-4434,"3350-3041 calBCE (4492±29 BP, OxA-31874)",4492,nan,Lazaridis et al. 2016,,,0,0,n/a (female),596,fasta,11467G;12308G;12372A;150T;16390A,11467;12308;12372;150;16390,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;POAG - potential for association,Reported;Conflicting reports,+,-;+
I1656,I1656,Armenia,,,Armenia_MBA,,Armenia_MBA,,40.377222,43.938333,F,Katnaghbiur 1,,T1a2,n/a (female),-3168,-3114,"1502-1402 calBCE (3168±27 BP, OxA-31674)",3168,nan,Lazaridis et al. 2016,,,0,0,n/a (female),404,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
Bul4,Bul4,Bulgaria,,,Bulgaria_EBA_Yamnaya_o,,Bulgaria_EBA_Yamnaya_o,,42.4296241,25.8983541,M,"Nova Zagora, Mednikarovo",,..,..,-4333,-4293,"3011-2898 calBCE (4333±20 BP, MAMS-26834)",4333,nan,Mathieson et al. 2018,,,0,0,..,..,fasta,,,,,,,
RISE21,RISE21_noUDG.SG,Denmark,,,Denmark_BA.SG,,Denmark_BA.SG,,55.55,12.209,M,Karlstrup,,N1a1a1a2,..,-3092,-3034,"1426-1272 calBCE (3092±29 BP, OxA-28047)",3092,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE47,RISE47_noUDG.SG,Denmark,,,Denmark_BA.SG,,Denmark_BA.SG,,56.97,9.552,M,Sebber skole,,I,..,-3153,-3101,"1499-1322 calBCE (3153±26 BP, OxA-28258)",3153,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE276,RISE276_noUDG.SG,Denmark,,,Denmark_LBA.SG,,Denmark_LBA.SG,,55.914,11.565,M,Trundholm II,,T2b,..,-2525,-2475,"789-546 calBCE (2525±25 BP, OxA-30485)",2525,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE42,RISE42_noUDG.SG,Denmark,,,Denmark_LN_o.SG,,Denmark_LN_o.SG,,55.657,12.148,M,Marbjerg,,H3v+16093,..,-3681,-3625,"2193-1971 calBCE (3681±28 BP, OxA-28225)",3681,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE71,RISE71_noUDG.SG,Denmark,,,Denmark_LN.SG,,Denmark_LN.SG,,56.676,10.034,F,Falshöj,,H3b,n/a (female),-3701,-3649,"2197-1983 calBCE (3701±26 BP, OxA-28269)",3701,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
RISE61,RISE61_noUDG.SG,Denmark,,,Denmark_MN_B.SG,,Denmark_MN_B.SG,,55.703,11.855,M,Kyndelöse,,J1c4,..,-4071,-4017,"2848-2492 calBCE (4071±27 BP, OxA-28296)",4071,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
JK2888,JK2888,Egypt,,,Egypt_Ptolemaic_contam,,Egypt_Ptolemaic_contam,,29.9,31.2,M,Abusir-el Meleq,,U6a2,..,-2050,-2002,"151 calBCE - 23 calCE (2050±24 BP, MAMS-23575)",2050,nan,Scheunemann et al. 2017,,,0,0,..,..,fasta,,,,,,,
JK2134,JK2134,Egypt,,,Egypt_ThirdIntermediatePeriod,,Egypt_ThirdIntermediatePeriod,,29.9,31.2,M,Abusir-el Meleq,,J1d,..,-2522,-2474,"787-546 calBCE (2522±24 BP, MAMS-23047)",2522,nan,Scheunemann et al. 2017,,,0,0,..,..,fasta,,,,,,,
JK2911,JK2911,Egypt,,,Egypt_ThirdIntermediatePeriod,,Egypt_ThirdIntermediatePeriod,,29.9,31.2,M,Abusir-el Meleq,,M1a1,..,-2513,-2465,"779-544 calBCE (2513±24 BP, MAMS-23617)",2513,nan,Scheunemann et al. 2017,,,0,0,..,..,fasta,,,,,,,
Chaudardes1,Chaudardes1_noUDG,France,,,France_Chaudardes,,France_Chaudardes,,49.24,3.46,M,Chaudardes,,U5b1b,I,-7400,-7280,"6400-6086 calBCE (7400±60 BP, GrA-28268)",7400,nan,Fu et al. 2016,,,0,0,..,..,fasta,,,,,,,
SATP,SATP_noUDG.SG,Georgia,,,Georgia_Satsurblia.SG,,Georgia_Satsurblia.SG,,42.38,42.59,M,Satsurblia,,K3,..,-1415,-1315,"11461-11225 calBCE (11415±50 BP, OxA-34632)",1415,nan,Jones et al. 2015,,,0,0,..,..,fasta,,,,,,,
I0108,I0108,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.45,11.54,F,Rothenschirmbach,,H5a3,n/a (female),-3953,-3859,"2575-2297 calBCE (3953±47 BP, Erl-8710)",3953,nan,Mathieson et al. 2015,,,0,0,n/a (female),271.808981,fasta,4336C,4336,MT-TQ,ADPD / Hearing Loss & Migraine / autism spectrum / intellectual disability,Unclear,+,+
I0111,I0111,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.45,11.54,F,Rothenschirmbach,,H3ao,n/a (female),-3881,-3781,"2474-2201 calBCE (3881±50 BP, Erl-8712)",3881,nan,Mathieson et al. 2015,,,0,0,n/a (female),188.260668,fasta,,,,,,,
I0112,I0112,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.791,11.141,F,Quedlinburg Site XII,,H13a1a2,n/a (female),-3820,-3736,"2455-2141 calBCE (3820±42 BP, Erl-7038)",3820,nan,Mathieson et al. 2015,,,0,0,n/a (female),227.673245,fasta,,,,,,,
I0113,I0113,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.791,11.141,F,Quedlinburg Site XII,,J1c5,n/a (female),-3773,-3679,"2396-2034 calBCE (3773±47 BP, Erl-7283)",3773,nan,Mathieson et al. 2015,,,0,0,n/a (female),8.427183,fasta,462T;13708A;489C;3010A;10398G;295T;4216C;11251G;185A;228A,462;13708;489;3010;10398;295;4216;11251;185;228,MT-CR;MT-ND5;MT-RNR2;MT-ND3;MT-ND1;MT-ND4,Low VO2max response;LHON / Increased MS risk / higher freq in PD-ADS;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Reported;Conflicting reports;Reported / lineage L & M marker / also hg IJK,+;nr,-;+;nr
I0806,I0806,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.79,11.14,M,Quedlinburg Site VII,,H1,R1b1a2a1a2,-3824,-3774,"2433-2147 calBCE (3824±25 BP, MAMS-22820)",3824,nan,Mathieson et al. 2015,,,0,0,..,268,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I1530,I1530,Germany,,,Germany_BellBeaker_1d.rel.I0111,,Germany_BellBeaker_1d.rel.I0111,,51.45,11.54,M,Rothenschirmbach,,H3ao,R1,-3818,-3722,"2456-2140 calBCE (3818±48 BP, Erl-8715)",3818,nan,Mathieson et al. 2015,,,0,0,..,148.841994,fasta,,,,,,,
I0805,I0805,Germany,,,Germany_BellBeaker_contam,,Germany_BellBeaker_contam,,51.79,11.14,M,Quedlinburg Site VII,,H1,R1b1a2,-3839,-3729,"2465-2142 calBCE (3839±55 BP, Erl-8558)",3839,nan,Mathieson et al. 2015,,,0,0,..,199,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I0060,I0060,Germany,,,Germany_BellBeaker,,Germany_BellBeaker,,51.45,11.54,F,Rothenschirmbach,,K1a2c,n/a (female),-3822,-3772,"2404-2146 calBCE (3822±25 BP, MAMS-22819)",3822,nan,Mathieson et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
I0171,I0171,Germany,,,Germany_BenzigerodeHeimburg_LN,,Germany_BenzigerodeHeimburg_LN,,51.82,10.91,F,Benzingerode-Heimburg,,U5a1a2a,n/a (female),-3758,-3692,"2288-2039 calBCE (3758±33 BP, KIA-27952)",3758,nan,Mathieson et al. 2015,,,0,0,n/a (female),160.013399,fasta,11467G;12308G;12372A;16270T,11467;12308;12372;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I0803,I0803,Germany,,,Germany_EBA_Unetice,,Germany_EBA_Unetice,,51.167663,11.847527,F,Eulau,,H4a1a1a,n/a (female),-3650,-3598,"2135-1941 calBCE (3650±26 BP, MAMS-22822)",3650,nan,Mathieson et al. 2015,,,0,0,n/a (female),200,fasta,10044G;14582G,10044;14582,MT-TG;MT-ND6,SIDS;LHON synergistic combo 14258A + 14582G,Unclear;Reported: individually neutral variants causing LHON in combination,-;+,+;-
I0804,I0804,Germany,,,Germany_EBA_Unetice,,Germany_EBA_Unetice,,51.167663,11.847527,M,Eulau,,H3,I2,-3671,-3619,"2139-1959 calBCE (3671±26 BP, MAMS-22821)",3671,nan,Mathieson et al. 2015,,,0,0,..,131,fasta,,,,,,,
I2008,I2008,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,N1a1a1,n/a (female),-6137,-6067,"5211-4957 calBCE (6137±35 BP, KIA-40342)",6137,nan,Lipson et al. 2017,,,0,0,n/a (female),..,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;NaN;-,-;NaN;+
I2029,I2029,Germany,,,Germany_EN_LBK,,Germany_EN_LBK,,51.89583333,11.04666667,F,Halberstadt-Sonntagsfeld,,K1,n/a (female),-6211,-6147,"5299-5049 calBCE (6211±32 BP, KIA-40349)",6211,nan,Lipson et al. 2017,,,0,0,n/a (female),..,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
POST_2,POST_2,Germany,,,Germany_Lech_EBA,,Germany_Lech_EBA,,48.29573,10.89103,F,Haunstetten - Postillionstraße,,,n/a (female),-3648,-3610,"2131-1946 calBCE (3648±19 BP, MAMS-18953)",3648,nan,Mittnik et al. 2019,,,0,0,n/a (female),..,fasta,,,,,,,
POST_99,POST_99_d,Germany,,,Germany_Lech_EBA,,Germany_Lech_EBA,,48.29573,10.89103,F,Haunstetten - Postillionstraße,,K1a4a1,n/a (female),-3641,-3591,"2133-1931 calBCE (3641±25 BP, MAMS-18969)",3641,nan,Mittnik et al. 2019,,,0,0,n/a (female),..,fasta,,,,,,,
UNTA85_1412,UNTA85_1412,Germany,,,Germany_Lech_EBA,,Germany_Lech_EBA,,48.31966,10.89153,M,Haunstetten - Unterer Talweg 85,,H,R1b1a2,-3602,-3552,"2028-1891 calBCE (3602±25 BP, MAMS-18951)",3602,nan,Mittnik et al. 2019,,,0,0,..,..,fasta,,,,,,,
POST_99,POST_99,Germany,,,Germany_Lech_EBA_possible.contam,,Germany_Lech_EBA_possible.contam,,48.29573,10.89103,F,Haunstetten - Postillionstraße,,K1a4a1,n/a (female),-3641,-3591,"2133-1931 calBCE (3641±25 BP, MAMS-18969)",3641,nan,Mittnik et al. 2019,,,0,0,n/a (female),..,fasta,,,,,,,
I0118,I0118,Germany,,,Germany_LN_Alberstedt,,Germany_LN_Alberstedt,,51.45,11.63,F,Alberstedt,,H+16311,n/a (female),-3892,-3828,"2469-2238 calBCE (3892±32 BP, MAMS-21492)",3892,nan,Mathieson et al. 2015,,,0,0,n/a (female),231.954312,fasta,,,,,,,
I0550,I0550,Germany,,,Germany_LN_Karsdorf,,Germany_LN_Karsdorf,,51.28305556,11.65,F,Karsdorf,,T1a1,n/a (female),-3993,-3951,"2572-2467 calBCE (3993±21 BP, MAMS-23344)",3993,nan,Mathieson et al. 2015,,,0,0,n/a (female),201.003199,fasta,11251G;15928A;16189C;195C;4216C;4917G,11251;15928;16189;195;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-;+
I0560,I0560,Germany,,,Germany_MN_Baalberge,,Germany_MN_Baalberge,,51.792,11.142,F,Quedlinburg Site IX,,T2e1,n/a (female),-4745,-4641,"3637-3376 calBCE (4745±52 BP, Erl-7856)",4745,nan,Mathieson et al. 2015,,,0,0,n/a (female),231.918945,fasta,11251G;150T;15928A;4216C;4917G,11251;150;15928;4216;4917,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Longevity / Cervical Carcinoma / HPV infection risk;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;+;-
I0807,I0807,Germany,,,Germany_MN_Baalberge,,Germany_MN_Baalberge,,51.42,11.68,M,Esperstedt,,H1e1a,..,-5061,-4937,"3977-3659 calBCE (5061±62 BP, Erl-7784)",5061,nan,Mathieson et al. 2015,,,0,0,..,48.9,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I0172,I0172,Germany,,,Germany_MN_Esperstedt,,Germany_MN_Esperstedt,,51.42,11.68,M,Esperstedt,,T2b,..,-4502,-4406,"3363-3029 calBCE (4502±48 BP, Erl-8699)",4502,nan,Mathieson et al. 2015,,,0,0,..,1182.455489,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
MX280,MX280,Germany,,,Germany_SouthernGermany_Singen_EBA,,Germany_SouthernGermany_Singen_EBA,,47.767097,8.872239,F,"Southern Germany, Singen",,U5a1,n/a (female),-3620,-3576,"2111-1897 calBCE (3620±22 BP, MAMS-21975)",3620,nan,Furtwangler et al. 2020,,,0,0,n/a (female),..,fasta,,,,,,,
I2937,I2937,Greece,,,Greece_Peloponnese_N,,Greece_Peloponnese_N,,36.63833333,22.3825,F,"Diros, Alepotrypa Cave",,K1a+195,n/a (female),-6441,-6365,"5477-5331 calBCE (6441±38 BP, OxA-22012)",6441,nan,Lazaridis et al. 2017,,,0,0,n/a (female),62.143521,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I2937,I2937_noUDG,Greece,,,Greece_Peloponnese_N_noUDG,,Greece_Peloponnese_N_noUDG,,36.63833333,22.3825,F,"Diros, Alepotrypa Cave",,K1a+195,n/a (female),-6441,-6365,"5477-5331 calBCE (6441±38 BP, OxA-22012)",6441,nan,Lazaridis et al. 2017,,,0,0,n/a (female),62.143521,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I1497,CO1_noUDG.SG,Hungary,,,Hungary_Baden_LateCA.SG,,Hungary_Baden_LateCA.SG,,47.167,19.833,F,Apc-Berekalya I,,H,n/a (female),-4421,-4367,"3320-2922 calBCE (4421±27 BP, MAMS-14825)",4421,nan,Gamba et al. 2014,,,0,0,n/a (female),..,fasta,,,,,,,
SZ43,SZ43.SG,Hungary,,,Hungary_Langobard_o1.SG,,Hungary_Langobard_o1.SG,,46.28333333,17.85,M,Szólád,,H1e,..,-1521,-1471,438-605 calCE (1521±25 BP),1521,nan,Amorim et al. 2018,,,0,0,..,140.37,fasta,,,,,,,
I1497,I1497,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.167,19.833,F,Apc-Berekalya I,,H,n/a (female),-4421,-4367,"3320-2922 calBCE (4421±27 BP, MAMS-14825)",4421,nan,Mathieson et al. 2015,,,0,0,n/a (female),445,fasta,,,,,,,
I2369,I2369,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.62094,19.04494,M,Budakalász-Luppa csárda,,J2a1a1,..,-4545,-4475,"3370-3101 calBCE (4545±35 BP, Poz-83634)",4545,nan,Lipson et al. 2017,,,0,0,..,125,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2371,I2371,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.31875,19.16692,M,Alsónémedi,,U5b,..,-4520,-4450,"3361-3099 calBCE (4520±35 BP, Poz-83635)",4520,nan,Lipson et al. 2017,,,0,0,..,42,fasta,11467G;12308G;12372A;150T;16129A;16270T,11467;12308;12372;150;16129;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Cyclic Vomiting Syndrome with Migraine;Melanoma patients,Reported;Conflicting reports,+;-;nr,-;+;nr
I2753,I2753,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.78469,17.731714,M,Balatonlelle-Felső-Gamász,,U5a1,..,-4440,-4370,"3333-2928 calBCE (4440±35 BP, Poz-88231)",4440,nan,Lipson et al. 2017,,,0,0,..,315,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I2754,I2754,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.78469,17.731714,M,Balatonlelle-Felső-Gamász,,J1c+16261+189,..,-4465,-4405,"3338-3024 calBCE (4465±30 BP, Poz-83637)",4465,nan,Lipson et al. 2017,,,0,0,..,71.9,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2763,I2763,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,46.665765,17.270774,F,Vörs,,T2,n/a (female),-4528,-4466,"3363-3101 calBCE (4528±31 BP, DeA-14662)",4528,nan,Lipson et al. 2017,,,0,0,n/a (female),555,fasta,11251G;15928A;16189C;4216C;4917G,11251;15928;16189;4216;4917,MT-ND4;MT-TT;MT-CR;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I2366,I2366,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.62094,19.04494,M,"Budakalász, Luppa csárda",,H26a,..,-4455,-4385,"3340-2937 calBCE (4455±35 BP, Poz-88227)",4455,nan,Lipson et al. 2017,,,0,0,..,..,fasta,,,,,,,
I2367,I2367,Hungary,,,Hungary_LateC_Baden,,Hungary_LateC_Baden,,47.62094,19.04494,M,"Budakalász, Luppa csárda",,HV,..,-4440,-4370,"3333-2928 calBCE (4440±35 BP, Poz-88228)",4440,nan,Lipson et al. 2017,,,0,0,..,..,fasta,,,,,,,
I2788,I2788,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,M,"Abony, Turjányos-dűlő",,H,..,-4960,-4880,"3910-3644 calBCE (4960±40 BP, VERA-5402)",4960,nan,Lipson et al. 2017,,,0,0,..,334,fasta,,,,,,,
I2790,I2790,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,F,"Abony, Turjános-dülö",,N1a1a3,n/a (female),-4890,-4820,"3768-3543 calBCE (4890±35 BP, Poz-82205)",4890,nan,Lipson et al. 2017,,,0,0,n/a (female),..,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;NaN;-,-;NaN;+
I2791,I2791,Hungary,,,Hungary_LateC_Protoboleraz,,Hungary_LateC_Protoboleraz,,47.189141,20.004795,M,"Abony, Turjános-dülö",,U5a1c1,..,-4800,-4720,"3649-3516 calBCE (4800±40 BP, Poz-82206)",4800,nan,Lipson et al. 2017,,,0,0,..,..,fasta,11467G;12308G;12372A;16192T;16270T;195C,11467;12308;12372;16192;16270;195,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients;BD-associated / melanoma pts,Reported,+;nr,-;+;nr
I1498,I1498,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.524728,21.58557,F,Debrecen Tocopart Erdoalja,,H,n/a (female),-6207,-6147,"5297-5048 calBCE (6207±30 BP, OxA-27858)",6207,nan,Mathieson et al. 2015,,,0,0,n/a (female),465,fasta,,,,,,,
I1500,I1500,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.167,20.833,M,Kompolt-Kigyoser,,J1c1,..,-6164,-6036,"5301-4940 calBCE (6164±64 BP, OxA-23763)",6164,nan,Mathieson et al. 2015,,,0,0,..,528,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1505,I1505,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,J1c5,n/a (female),-6153,-6087,"5210-5003 calBCE (6153±33 BP, OxA-28020)",6153,nan,Mathieson et al. 2015,,,0,0,n/a (female),142,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1506,I1506,Hungary,,,Hungary_MN_ALPc,,Hungary_MN_ALPc,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,U5b2c,n/a (female),-6237,-6173,"5306-5064 calBCE (6237±32 BP, OxA-27861)",6237,nan,Mathieson et al. 2015,,,0,0,n/a (female),220,fasta,11467G;12308G;12372A;13637G;150T;16270T,11467;12308;12372;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1499,I1499,Hungary,,,Hungary_MN_ALPc_Bukk,,Hungary_MN_ALPc_Bukk,,48.52,21.168,F,Garadna,,X2b+226,n/a (female),-6185,-6117,"5286-5015 calBCE (6185±34 BP, OxA-27732)",6185,nan,Mathieson et al. 2015,,,0,0,n/a (female),320,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I1499,NE3_noUDG.SG,Hungary,,,Hungary_MN_ALPc_Bukk.SG,,Hungary_MN_ALPc_Bukk.SG,,48.52,21.168,F,Garadna,,X2b-T226C,n/a (female),-6185,-6117,"5286-5015 calBCE (6185±34 BP, OxA-27732)",6185,nan,Gamba et al. 2014,,,0,0,n/a (female),..,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I1498,NE2_noUDG.SG,Hungary,,,Hungary_MN_ALPc.SG,,Hungary_MN_ALPc.SG,,47.524728,21.58557,F,Debrecen Tocopart Erdoalja,,H,n/a (female),-6207,-6147,"5297-5048 calBCE (6207±30 BP, OxA-27858)",6207,nan,Gamba et al. 2014,,,0,0,n/a (female),..,fasta,,,,,,,
I1500,NE5_noUDG.SG,Hungary,,,Hungary_MN_ALPc.SG,,Hungary_MN_ALPc.SG,,47.167,20.833,M,Kompolt-Kigyoser,,J1c1,C1a2,-6164,-6036,"5301-4940 calBCE (6164±64 BP, OxA-23763)",6164,nan,Gamba et al. 2014,,,0,0,..,..,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1505,NE4_noUDG.SG,Hungary,,,Hungary_MN_ALPc.SG,,Hungary_MN_ALPc.SG,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,J1c5,n/a (female),-6153,-6087,"5210-5003 calBCE (6153±33 BP, OxA-28020)",6153,nan,Gamba et al. 2014,,,0,0,n/a (female),..,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1506,NE1_noUDG.SG,Hungary,,,Hungary_MN_LBK.SG,,Hungary_MN_LBK.SG,,47.846464,21.149429,F,"Polgár-Ferenci hát, M3-31",,U5b2c,n/a (female),-6237,-6173,"5306-5064 calBCE (6237±32 BP, OxA-27861)",6237,nan,Gamba et al. 2014,,,0,0,n/a (female),..,fasta,11467G;12308G;12372A;13637G;150T;16270T,11467;12308;12372;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1661,I1661,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,F,Seh Gabi,,H29,n/a (female),-5740,-5660,"4700-4461 calBCE (5740±40 BP, Poz-81104)",5740,nan,Lazaridis et al. 2016,,,0,0,n/a (female),510.913453,fasta,,,,,,,
I1662,I1662,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,M,Seh Gabi,,K1a12a,..,-5860,-5780,"4836-4610 calBCE (5860±40 BP, Poz-81105)",5860,nan,Lazaridis et al. 2016,,,0,0,..,432,fasta,10398G;11467G;12308G;12372A;16093C;5460A;9055A,10398;11467;12308;12372;16093;5460;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ND2;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;AD / PD / LHON;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I1665,I1665,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,F,Seh Gabi,,U7a,n/a (female),-5070,-5010,"3957-3792 calBCE (5070±30 BP, Poz-81106)",5070,nan,Lazaridis et al. 2016,,,0,0,n/a (female),595,fasta,10142T;11467G;12308G;12372A,10142;11467;12308;12372,MT-ND3;MT-ND4;MT-TL2;MT-ND5,Recurrent pregnancy loss;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD,Reported,nr;+,nr;-;+
I1670,I1670,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,F,Seh Gabi,,U3a'c,n/a (female),-5870,-5790,"4840-4615 calBCE (5870±40 BP, Poz-81107)",5870,nan,Lazaridis et al. 2016,,,0,0,n/a (female),19.313236,fasta,11467G;12308G;12372A;150T,11467;12308;12372;150,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk,Reported;Conflicting reports,+,-;+
I1674,I1674,Iran,,,Iran_C_SehGabi,,Iran_C_SehGabi,,34.5,47.96,M,Seh Gabi,,I1c,..,-5105,-5035,"3978-3798 calBCE (5105±35 BP, Poz-81108)",5105,nan,Lazaridis et al. 2016,,,0,0,..,334,fasta,10398G;12705T;15043A;15924G;16129A;8573A;9966A,10398;12705;15043;15924;16129;8573;9966,MT-ND3;MT-CO1;MT-CYB;MT-TT;MT-CR;MT-ATP6;MT-CO3,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;LIMM;Cyclic Vomiting Syndrome with Migraine;Patient with suspected mitochondrial disease;LHON possible helper variant,Reported / lineage L & M marker / also hg IJK;Reported;Reported as Benign,+;NaN;nr;-,-;NaN;nr;+
I1290,I1290,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,X1'2'3,n/a (female),-8780,-8680,"8170-7606 calBCE (8780±50 BP, Poz-81100)",8780,nan,Lazaridis et al. 2016,,,0,0,n/a (female),112.02565,fasta,12705T;16189C,12705;16189,MT-CO1;MT-CR,Possible protective factor for normal tension glaucoma;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported,NaN;+,NaN;-
I1949,I1949,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,M,Ganj Dareh,,R2b,CT,-8915,-8835,"8242-7954 calBCE (8915±40 BP, PSUAMS-2261)",8915,nan,Narasimhan et al. 2019,,,0,0,..,13.450057,fasta,4216C,4216,MT-ND1,LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Conflicting reports,+,-
I1951,I1951,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,HV,n/a (female),-8800,-8700,"8198-7613 calBCE (8800±50 BP, Poz-81109)",8800,nan,Narasimhan et al. 2019,,,0,0,n/a (female),13.102963,fasta,,,,,,,
rath1,rath1_noUDG.SG,Ireland,,,Ireland_EBA.SG,,Ireland_EBA.SG,,55.292132,-6.191685,M,"Rathlin Island,  County Antrim",,U5a1b1e,R1b1a1b1a1a2c1a5,-3591,-3533,"2031-1830 calBCE (3591±29 BP, UBA-8707)",3591,nan,Cassidy et al. 2016,,,0,0,R-DF21,..,fasta,,,,,,,
rath2,rath2_noUDG.SG,Ireland,,,Ireland_EBA.SG,,Ireland_EBA.SG,,55.292132,-6.191685,M,"Rathlin Island,  County Antrim",,U5b2a2,R1b1a1b1a1a2c1a5c,-3539,-3431,"2026-1700 calBCE (3539±54 BP, UBA-8705)",3539,nan,Cassidy et al. 2016,,,0,0,R-S5488,..,fasta,,,,,,,
rath3,rath3_noUDG.SG,Ireland,,,Ireland_EBA.SG,,Ireland_EBA.SG,,55.292132,-6.191685,M,"Rathlin Island,  County Antrim",,J2b1a,R1b1a1b1a1a2c1,-3354,-3298,"1736-1539 calBCE (3354±28 BP, UBA-8706)",3354,nan,Cassidy et al. 2016,,,0,0,R-L21,..,fasta,,,,,,,
bally,bally_noUDG.SG,Ireland,,,Ireland_N.SG,,Ireland_N.SG,,54.54222222,-5.956666667,F,"Ballynahatty,  County Down",,HV0+195,n/a (female),-4465,-4389,"3346-3014 calBCE (4465±38 BP, UBA-7059)",4465,nan,Cassidy et al. 2016,,,0,0,n/a (female),..,fasta,,,,,,,
I1687,I1687_d,Israel,,,Israel_Natufian_lc,,Israel_Natufian_lc,,32.65,35.067,F,Raqefet Cave,,n/a (<2x),n/a (female),-1405,-1381,"11541-11150 calBCE (11405±120 BP, RTK-6607)",1405,nan,Lazaridis et al. 2022,,,0,0,n/a (female),0.608787,fasta,,,,,,,
I1687,I1687,Israel,,,Israel_Natufian_contam,,Israel_Natufian_contam,,32.65,35.067,F,Raqefet Cave,,H2a,n/a (female),-1405,-1381,"11541-11150 calBCE (11405±120 BP, RTK-6607)",1405,nan,Lazaridis et al. 2016,,,0,0,n/a (female),2.536363,fasta,,,,,,,
RISE487,RISE487_noUDG.SG,Italy,,,Italy_North_Remedello_C.SG,,Italy_North_Remedello_C.SG,,45.26,10.379,M,"Lombardy, Remedello di Sotto",,H2a,..,-4557,-4501,"3485-3103 calBCE (4557±28 BP, OxA-X-2621)",4557,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE489,RISE489_noUDG.SG,Italy,,,Italy_North_Remedello_C.SG,,Italy_North_Remedello_C.SG,,45.26,10.379,M,"Lombardy, Remedello di Sotto",,X2c1,..,-4185,-4045,"2909-2576 calBCE (4185±70 BP, ETH-12188)",4185,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE486,RISE486_noUDG.SG,Italy,,,Italy_North_Remedello_EBA.SG,,Italy_North_Remedello_EBA.SG,,45.26,10.379,M,"Lombardy, Remedello di Sotto",,J1c1b,..,-3595,-3485,"2136-1771 calBCE (3595±55 BP, ETH-12913)",3595,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
I1705,I1705,Jordan,,,Jordan_EBA,,Jordan_EBA,,31.988,35.976,M,'Ain Ghazal,,H14a,J1(xJ1a) ,-3690,-3620,"2198-1961 calBCE (3690±35 BP, Poz-81096)",3690,nan,Lazaridis et al. 2016,,,0,0,..,671,fasta,,,,,,,
I1730,I1730,Jordan,,,Jordan_EBA,,Jordan_EBA,,31.988,35.976,M,'Ain Ghazal,,R0a1a,"J(xJ1,J2a,J2b2a) ",-3925,-3863,"2557-2296 calBCE (3925±31 BP, OxA-32775)",3925,nan,Lazaridis et al. 2016,,,0,0,..,470,fasta,146C;827G,146;827,MT-CR;MT-RNR1,Absence of Endometriosis;DEAF,Reported;Conflicting reports,+,-
ERS1790733,ERS1790733_noUDG.SG,Lebanon,,,Lebanon_MBA.SG,,Lebanon_MBA.SG,,33.561623,35.371184,M,"Sidon, College Site",,N1a3a,..,-3505,-3415,"1950-1692 calBCE (3505±45 BP, VERA-3890)",3505,nan,Haber et al. 2017,,,0,0,..,..,fasta,,,,,,,
RISE598,RISE598_noUDG.SG,Lithuania,,,Lithuania_LBA.SG,,Lithuania_LBA.SG,,54.358,23.302,M,Turlojiske,,H2a2,..,-2590,-2440,"906-477 calBCE (2590±75 BP, Ua-16681)",2590,16681,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
ARS001,ARS001.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.656833,99.726694,M,"Khovsgol aimag, Arbulag sorum",,D4,..,-2779,-2679,"1048-816 calBCE (2779±50 BP, A-)",2779,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS002,ARS002.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.659472,99.72775,F,"Khovsgol aimag, Arbulag sorum",,D4j5,n/a (female),-2910,-2806,"1261-932 calBCE (2910±52 BP, A-)",2910,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS003,ARS003.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.506111,99.69325,M,"Khovsgol aimag, Arbulag sorum",,U5a2d1,..,-3044,-2944,"1423-1127 calBCE (3044±50 BP, A-)",3044,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS004,ARS004.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.692222,99.766361,M,"Khovsgol aimag, Arbulag sorum",,F2a,..,-2857,-2749,"1211-901 calBCE (2857±54 BP, A-)",2857,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS005,ARS005.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.692583,99.76675,M,"Khovsgol aimag, Arbulag sorum",,D4e1,..,-2897,-2787,"1257-926 calBCE (2897±55 BP, A-)",2897,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS006,ARS006.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.690139,99.760694,F,"Khovsgol aimag, Arbulag sorum",,C4a1a+195 ,n/a (female),-2872,-2776,"1207-920 calBCE (2872±48 BP, A-)",2872,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS007,ARS007.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.689639,99.773611,M,"Khovsgol aimag, Arbulag sorum",,A+152+16362 ,..,-2991,-2895,"1389-1054 calBCE (2991±48 BP, A-)",2991,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS008,ARS008.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.690444,99.773917,M,"Khovsgol aimag, Arbulag sorum",,C4a2c ,..,-2992,-2896,"1390-1055 calBCE (2992±48 BP, A-)",2992,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS011,ARS011.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657333,99.725944,M,"Khovsgol aimag, Arbulag sorum",,..,..,-2930,-2830,"1283-940 calBCE (2930±50 BP, A-)",2930,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS012,ARS012.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657361,99.726389,F,"Khovsgol aimag, Arbulag sorum",,C4a2a1 ,n/a (female),-3029,-2931,"1412-1126 calBCE (3029±49 BP, A-)",3029,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS013,ARS013.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.6575,99.727556,F,"Khovsgol aimag, Arbulag sorum",,C,n/a (female),-3074,-2976,"1446-1204 calBCE (3074±49 BP, A-)",3074,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS014,ARS014.B0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.6575,99.723667,F,"Khovsgol aimag, Arbulag sorum",,C4a2c1,n/a (female),-3033,-2935,"1415-1127 calBCE (3033±49 BP, A-)",3033,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS015,ARS015.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.65725,99.725833,M,"Khovsgol aimag, Arbulag sorum",,G3a ,..,-3052,-2948,"1431-1128 calBCE (3052±52 BP, A-)",3052,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS016,ARS016.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657222,99.726,M,"Khovsgol aimag, Arbulag sorum",,A+152+16362+16189 ,..,-3174,-3068,"1539-1291 calBCE (3174±53 BP, A-)",3174,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS017,ARS017.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657194,99.725778,F,"Khovsgol aimag, Arbulag sorum",,G2a,n/a (female),-3052,-2952,"1428-1130 calBCE (3052±50 BP, A-)",3052,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS018,ARS018.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.657167,99.725944,M,"Khovsgol aimag, Arbulag sorum",,B5b1,..,-2835,-2735,"1191-839 calBCE (2835±50 BP, A-)",2835,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS024,ARS024.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.695556,99.778667,F,"Khovsgol aimag, Arbulag sorum",,C4a1a1 ,n/a (female),-2990,-2914,"1385-1057 calBCE (2990±38 BP, A-)",2990,nan,Jeong et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
ARS025,ARS025.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.683889,99.806333,M,"Khovsgol aimag, Arbulag sorum",,D4b1a2a ,..,-3056,-2964,"1427-1134 calBCE (3056±46 BP, A-)",3056,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
ARS026,ARS026.A0101,Mongolia,,,Mongolia_LBA_Khovsgol_6,,Mongolia_LBA_Khovsgol_6,,49.694333,99.780417,M,"Khovsgol aimag, Arbulag sorum",,C4a1a+195 ,..,-2842,-2758,"1189-899 calBCE (2842±42 BP, A-)",2842,nan,Jeong et al. 2018,,,0,0,..,..,fasta,,,,,,,
RISE1,RISE1_noUDG.SG,Poland,,,Poland_CordedWare_3.SG,,Poland_CordedWare_3.SG,,52.29,17.54,M,Oblaczkowo,,K1b1a1,..,-4117,-4061,"2866-2577 calBCE (4117±28 BP, UBA-16633)",4117,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE139,RISE139_noUDG.SG,Poland,,,Poland_EBA_Unetice.SG,,Poland_EBA_Unetice.SG,,50.796,17.094,M,Chociwel,,U2e1f1,..,-3645,-3579,"2137-1926 calBCE (3645±33 BP, Ua-44034)",3645,44034,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE145,RISE145_noUDG.SG,Poland,,,Poland_EBA_Unetice.SG,,Poland_EBA_Unetice.SG,,50.913,17.177,F,Polwica,,H6a1b,n/a (female),-3677,-3615,"2191-1956 calBCE (3677±31 BP, UB-16564)",3677,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
I3432,I3432,Portugal,,,Portugal_C,,Portugal_C,,38.387,-7.55,F,"Évora, Reguengos de Monsaraz, Perdigões",,U5b2b3,n/a (female),-4365,-4315,"3081-2907 calBCE (4365±25 BP, PSUAMS-1882)",4365,nan,Olalde et al. 2019,,,0,0,n/a (female),223,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T;2755G,11467;12308;12372;12634;13637;150;16270;2755,MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-RNR2,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Possibly LVNC-associated,Reported;Conflicting reports,+;nr,-;+;nr
I5076,I5076,Portugal,,,Portugal_C,,Portugal_C,,37.196772,-8.588546,F,Monte Canelas 1,,H1,n/a (female),-4465,-4415,"3336-3026 calBCE (4465±25 BP, PSUAMS-3902)",4465,nan,Olalde et al. 2019,,,0,0,n/a (female),205.418492,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I5428,I5428,Portugal,,,Portugal_C,,Portugal_C,,39.624062,-9.047189,M,Cova das Lapas,,U5b1+16189+@16192,..,-4510,-4460,"3352-3101 calBCE (4510±25 BP, PSUAMS-8227)",4510,nan,Olalde et al. 2019,,,0,0,..,24.5,fasta,11467G;12308G;12372A;150T;16270T,11467;12308;12372;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I5429,I5429,Portugal,,,Portugal_C,,Portugal_C,,38.387,-7.55,M,"Évora, Reguengos de Monsaraz, Perdigões",,J2b1a3,..,-4310,-4270,"3010-2886 calBCE (4310±20 BP, PSUAMS-2692)",4310,nan,Olalde et al. 2019,,,0,0,..,75.4,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
AfontovaGora3,AfontovaGora3_noUDG_d,Russia,,,Russia_AfontovaGora3,,Russia_AfontovaGora3,,56.05,92.87,F,Afontova Gora,,R1b,n/a (female),-4710,-4590,"16257-15905 calBCE (14710±60 BP, MAMS-27186)",4710,nan,Fu et al. 2016,,,0,0,n/a (female),..,fasta,,,,,,,
RISE515,RISE515_noUDG.SG,Russia,,,Russia_BA_Okunevo.SG,,Russia_BA_Okunevo.SG,,53.156486,90.207811,F,Verkhni Askiz,,A8a,n/a (female),-3810,-3760,"2343-2144 calBCE (3810±25 BP, UCIAMS-147669)",3810,nan,Damgaard et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
RISE516,RISE516_noUDG.SG,Russia,,,Russia_BA_Okunevo.SG_sister.RISE672.SG,,Russia_BA_Okunevo.SG_sister.RISE672.SG,,53.156486,90.207811,F,Verkhni Askiz,,H6a1b,n/a (female),-3725,-3675,"2201-2035 calBCE (3725±25 BP, UCIAMS-147668)",3725,nan,Damgaard et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
RISE555,RISE555_noUDG.SG,Russia,,,Russia_EBA_o1.SG,,Russia_EBA_o1.SG,,48.716,44.5,M,Stalingrad Quarry,,N1a1a-T152C,..,-4082,-4026,"2853-2495 calBCE (4082±28 BP, AA-R-20358)",4082,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE504,RISE504_noUDG.SG,Russia,,,Russia_IA_2.SG,,Russia_IA_2.SG,,53.456,85.447,M,Kytmanovo,,C4a1d,..,-1208,-1160,"709-888 calCE (1208±24 BP, OxA-31215)",1208,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE547,RISE547_noUDG.SG,Russia,,,Russia_Kalmykia_EBA_Yamnaya.SG,,Russia_Kalmykia_EBA_Yamnaya.SG,,46.539,43.699,M,Temrta IV,,T2a1a,..,-4175,-4105,"2886-2631 calBCE (4175±35 BP, GrA-58960)",4175,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE493,RISE493_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,53.152,91.05,M,Sabinka 2,,C4a1c,..,-3214,-3162,"1518-1427 calBCE (3214±26 BP, OxA-31211)",3214,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE496,RISE496_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,52.954,90.187,F,Arban 1,,U5a1a2a,n/a (female),-3070,-3014,"1416-1260 calBCE (3070±28 BP, OxA-31213)",3070,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
RISE502,RISE502_noUDG.SG,Russia,,,Russia_Karasuk_oRISE.SG,,Russia_Karasuk_oRISE.SG,,51.909,88.574,F,Bystrovka,,U5a1d,n/a (female),-3140,-3086,"1497-1308 calBCE (3140±27 BP, OxA-31214)",3140,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
Kostenki14,Kostenki14,Russia,,,Russia_Kostenki14,,Russia_Kostenki14,,51.23,39.3,M,Kostenki,,..,..,-3250,-3150,"37426-34726 calBCE (33250±500 BP, OxA-X-2395-15)",3250,nan,Fu et al. 2016,,,0,0,..,..,fasta,,,,,,,
Kostenki14,Kostenki14_noUDG.SG,Russia,,,Russia_Kostenki14.SG,,Russia_Kostenki14.SG,,51.23,39.3,M,Kostenki,,U2,..,-3250,-3150,"37426-34726 calBCE (33250±500 BP, OxA-X-2395-15)",3250,nan,Seguin et al. 2014,,,0,0,..,..,fasta,,,,,,,
RISE553,RISE553_noUDG.SG,Russia,,,Russia_LBA_1.SG,,Russia_LBA_1.SG,,56.016,92.866,M,Afontova Gora,,F1b,..,-2731,-2675,"927-812 calBCE (2731±28 BP, OxA-31140)",2731,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE554,RISE554_noUDG.SG,Russia,,,Russia_LBA_2.SG,,Russia_LBA_2.SG,,56.016,92.866,M,Afontova Gora,,F1b1b,..,-2782,-2722,"1009-835 calBCE (2782±30 BP, OxA-31141)",2782,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE523,RISE523_noUDG.SG,Russia,,,Russia_Mezhovskaya.SG,,Russia_Mezhovskaya.SG,,53.043,57.066,F,Kapova cave,,M12'G,n/a (female),-3192,-3118,"1531-1403 calBCE (3192±37 BP, OxA-31447)",3192,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
I4246,I4246,Spain,,,Spain_BellBeaker_oAfrica,,Spain_BellBeaker_oAfrica,,40.439,-3.501,M,"Madrid, San Fernando de Henares, Camino de las Yeseras",,M1a1b1,..,-3819,-3769,"2401-2146 calBCE (3819±25 BP) [R_combine: (3910±30 BP, PSUAMS-2119); (3650±40 BP, Beta-184837)]",3819,nan,Olalde et al. 2019,,,0,0,..,13.062526,fasta,10398G;12705T;15043A;16129A;16189C;195C;489C,10398;12705;15043;16129;16189;195;489,MT-ND3;MT-CO1;MT-CYB;MT-CR,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Cyclic Vomiting Syndrome with Migraine;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Low VO2max response,Reported / lineage L & M marker / also hg IJK;Reported,+;NaN;-,-;NaN;+
I1272,I1272,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,K1b1a,n/a (female),-4080,-4020,"2857-2492 calBCE (4080±30 BP, Beta-416456)",4080,nan,Mathieson et al. 2015,,,0,0,n/a (female),810,fasta,10398G;11467G;12308G;12372A;15257A;16093C;5913A;9055A,10398;11467;12308;12372;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I1277,I1277,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,H3,I2a2a,-3950,-3890,"2570-2342 calBCE (3950±30 BP, Beta-416457)",3950,nan,Mathieson et al. 2015,,,0,0,..,519,fasta,,,,,,,
I1281,I1281,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,F,"Burgos, Atapuerca, El Mirador Cave",,H1t,n/a (female),-4110,-4050,"2867-2573 calBCE (4110±30 BP, Beta-416458)",4110,nan,Mathieson et al. 2015,,,0,0,n/a (female),419,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I1838,I1838,Spain,,,Spain_C,,Spain_C,,42.63,-2.7,F,"Basque Country, Alava, Las Yurdinas II",,J1c3,n/a (female),-4470,-4370,"3356-2936 calBCE (4470±50 BP, Poz-83429)",4470,nan,Lipson et al. 2017,,,0,0,n/a (female),978,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I1843,I1843,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Alava, Alto de la Huesera",,U5b1+16189+@16192,n/a (female),-4340,-4296,"3015-2901 calBCE (4340±22 BP) [R_combine: (4390±30 BP, Beta-301225); (4290±30 BP, Beta-301226)]",4340,nan,Lipson et al. 2017,,,0,0,n/a (female),702,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1975,I1975,Spain,,,Spain_C,,Spain_C,,42.57,-2.55,M,"Basque Country, Alava, La Chabola de la Hechicera",,J1c,..,-4350,-4270,"3092-2893 calBCE (4350±40 BP, Beta-288937)",4350,nan,Lipson et al. 2017,,,0,0,..,20.1,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I1976,I1976,Spain,,,Spain_C,,Spain_C,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3,I2a1b1,-3960,-3900,"2571-2347 calBCE (3960±30 BP, Beta-299306)",3960,nan,Olalde et al. 2019,,,0,0,I-Y3259,110.65864,fasta,,,,,,,
I1981,I1981,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,F,"Basque Country, Alava, Alto de la Huesera",,J1c1,n/a (female),-4320,-4260,"3013-2889 calBCE (4320±30 BP, Beta-301223)",4320,nan,Lipson et al. 2017,,,0,0,n/a (female),162,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I2467,I2467,Spain,,,Spain_C,,Spain_C,,42.57,-2.62,M,"Basque Country, Alava, El Sotillo",,X2,..,-3900,-3820,"2474-2209 calBCE (3900±40 BP, Beta-299300)",3900,nan,Lipson et al. 2017,,,0,0,..,132,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I2473,I2473,Spain,,,Spain_C,,Spain_C,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3,..,-4250,-4190,"2916-2704 calBCE (4250±30 BP, Beta-299305)",4250,nan,Olalde et al. 2019,,,0,0,..,33.567445,fasta,,,,,,,
I3272,I3272,Spain,,,Spain_C,,Spain_C,,42.57,-2.55,M,"Basque Country, Alava, La Chabola de la Hechicera",,X2b+226,..,-4380,-4300,"3307-2899 calBCE (4380±40 BP, Beta-288933)",4380,nan,Lipson et al. 2017,,,0,0,..,45,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I4565,I4565,Spain,,,Spain_C,,Spain_C,,41.2916,1.0638,M,"Tarragona, Galls Carboners",,H5,..,-4355,-4315,"3022-2907 calBCE (4355±20 BP, PSUAMS-2866)",4355,nan,Olalde et al. 2019,,,0,0,..,509,fasta,,,,,,,
I8131,I8131,Spain,,,Spain_C,,Spain_C,,38.9777,-0.16037,F,"Valencian Community, València/Valencia, La Vital, Gandia",,J2b1,n/a (female),-3980,-3920,"2576-2356 calBCE (3980±30 BP, Beta-504712)",3980,nan,Olalde et al. 2019,,,0,0,n/a (female),3.919911,fasta,150T;13708A;489C;10398G;15257A;295T;4216C;11251G;15812A,150;13708;489;10398;15257;295;4216;11251;15812,MT-CR;MT-ND5;MT-ND3;MT-CYB;MT-ND1;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Reduced risk of PD,Conflicting reports;Reported;Reported / lineage L & M marker / also hg IJK;Reported / Secondary,+;nr,+;-;nr
I8569,I8569,Spain,,,Spain_C,,Spain_C,,40.302777,0.2797,M,"Valencian Community, Castelló/Castellón, Alcalá de Xivert, Cova dels Diablets",,H1ah,..,-4141,-4099,"2872-2626 calBCE (4141±21 BP, MAMS-18651)",4141,nan,Olalde et al. 2019,,,0,0,..,71.4,fasta,3010A;8950A,3010;8950,MT-RNR2;MT-ATP6,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LDYT,Reported,+,-
EHU001,EHU001,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,42.419214,-3.484745,M,"Castilla y León, Burgos, Monasterio de Rodilla, El Hundido",,U5a1b1,..,-3760,-3700,"2287-2041 calBCE (3760±30 BP, Beta-492280)",3760,nan,Olalde et al. 2019,,,0,0,..,..,fasta,,,,,,,
EHU002,EHU002,Spain,,,Spain_C_oSteppe,,Spain_C_oSteppe,,42.419214,-3.484745,M,"Castilla y León, Burgos, Monasterio de Rodilla, El Hundido",,K1a4a1,..,-3933,-3869,"2564-2299 calBCE (3933±32 BP, CSIC-1896)",3933,nan,Olalde et al. 2019,,,0,0,..,..,fasta,,,,,,,
I0581,I0581_d,Spain,,,Spain_C,,Spain_C,,42.33333333,-3.5,M,"Burgos, Atapuerca, El Mirador Cave",,X2b,..,-4210,-4150,"2900-2675 calBCE (4210±30 BP, Beta-416455)",4210,nan,Mathieson et al. 2015,,,0,0,..,..,fasta,,,,,,,
I3276,I3276,Spain,,,Spain_C,,Spain_C,,42.57,-2.57,M,"Basque Country, Alava, Alto de la Huesera",,V,G2a2a,-4390,-4330,"3096-2913 calBCE (4390±30 BP, Beta-301225)",4390,nan,Lipson et al. 2017,,,0,0,..,284.099946,fasta,,,,,,,
I1836,I1836,Spain,,,Spain_EBA,,Spain_EBA,,41.223,1.7742,M,"Sitges, Barcelona, Cova del Gegant",,U,..,-3310,-3240,"1684-1503 calBCE (3310±35 BP, Poz-83482)",3310,nan,Olalde et al. 2019,,,0,0,..,45.7,fasta,11467G;12308G;12372A;16192T;16270T,11467;12308;12372;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Melanoma patients,Reported,+;nr,-;+;nr
I1840,I1840,Spain,,,Spain_EBA,,Spain_EBA,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3ap,..,-3260,-3200,"1613-1450 calBCE (3260±30 BP, Beta-299302)",3260,nan,Olalde et al. 2019,,,0,0,..,489,fasta,,,,,,,
I1977,I1977,Spain,,,Spain_EBA,,Spain_EBA,,42.57,-2.62,F,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,U5b1+16189+@16192,n/a (female),-3260,-3200,"1613-1450 calBCE (3260±30 BP, Beta-299312)",3260,nan,Olalde et al. 2019,,,0,0,n/a (female),266,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I1982,I1982,Spain,,,Spain_EBA,,Spain_EBA,,42.9933,-2.11339,F,Ondarre,,X2,n/a (female),-3340,-3280,"1735-1532 calBCE (3340±30 BP, Beta-350136)",3340,nan,Olalde et al. 2019,,,0,0,n/a (female),3.06,fasta,13708A;195C;8393T;15927A;12705T,13708;195;8393;15927;12705,MT-ND5;MT-CR;MT-ATP8;MT-TT;MT-CO1,LHON / Increased MS risk / higher freq in PD-ADS;BD-associated / melanoma pts;Reversible brain pseudoatrophy;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Possible protective factor for normal tension glaucoma,Conflicting reports;Reported,+;-;NaN,+;-;NaN
I2471,I2471,Spain,,,Spain_EBA,,Spain_EBA,,42.57,-2.62,F,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,K1b1a,n/a (female),-3280,-3220,"1620-1462 calBCE (3280±30 BP, Beta-299311)",3280,nan,Olalde et al. 2019,,,0,0,n/a (female),29.909288,fasta,10398G;11467G;12308G;12372A;15257A;16093C;5913A;9055A,10398;11467;12308;12372;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I3484,I3484,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,M,"Ciudad Real, Terrinches, Castillejo del Bonete",,J1c1,..,-3720,-3580,"2343-1905 calBCE (3720±70 BP, Rome-1687)",3720,nan,Olalde et al. 2019,,,0,0,..,18.2,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I3487,I3487,Spain,,,Spain_EBA,,Spain_EBA,,38.6314,-0.8615,M,"Valencian Community, Alacant/Alicante, Villena, Cabezo Redondo",,H1e1a,..,-3365,-3325,"1739-1546 calBCE (3365±20 BP, PSUAMS-2161)",3365,nan,Olalde et al. 2019,,,0,0,..,136,fasta,3010A;5460A,3010;5460,MT-RNR2;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;AD / PD / LHON,Reported;Conflicting reports,+,-;+
I3494,I3494,Spain,,,Spain_EBA,,Spain_EBA,,38.8494,-0.87138,M,"Valencian Community, València/Valencia, La Font de la Figuera, Coveta del Frare",,J1c1b,..,-3515,-3455,"1928-1747 calBCE (3515±30 BP, CNA-1661.1.1)",3515,nan,Olalde et al. 2019,,,0,0,..,641,fasta,10398G;11251G;13708A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I3756,I3756,Spain,,,Spain_EBA,,Spain_EBA,,38.5781,-2.8417,M,"Ciudad Real, Terrinches, Castillejo del Bonete",,H1,..,-3565,-3515,"2017-1778 calBCE (3565±25 BP, PSUAMS-2077)",3565,nan,Olalde et al. 2019,,,0,0,..,264,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I3997,I3997,Spain,,,Spain_EBA,,Spain_EBA,,39.526799,-0.509749,M,"Valencia, Paterna, Lloma de Betxí",,K1a2b,..,-3400,-3320,"1874-1544 calBCE (3400±40 BP, Beta-195318)",3400,nan,Olalde et al. 2019,,,0,0,..,158.361518,fasta,10398G;11467G;12308G;12372A;16093C;9055A,10398;11467;12308;12372;16093;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I4562,I4562,Spain,,,Spain_EBA,,Spain_EBA,,41.2916,1.0638,F,"Tarragona, Galls Carboners",,H1,n/a (female),-3375,-3335,"1741-1613 calBCE (3375±20 BP, PSUAMS-3191)",3375,nan,Olalde et al. 2019,,,0,0,n/a (female),193,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I6470,I6470,Spain,,,Spain_EBA,,Spain_EBA,,42.725112,-3.84239,M,"Castilla y León, Ciempozuelos, Burgos, Tablada de Rudrón, Virgazal",,J1c1,R1b1a1b1a1a2a (R-DF27),-3375,-3305,"1746-1540 calBCE (3375±35 BP, Poz-49177)",3375,nan,Olalde et al. 2019,,,0,0,R-L151 > P312 > DF27 > ZZ12 > Y30817,1012.714044,fasta,10398G;11251G;13708A;185A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
I6618,I6618,Spain,,,Spain_EBA,,Spain_EBA,,40.22,-3.76,M,"Madrid, Humanejos",,U5b3,..,-3458,-3410,"1880-1691 calBCE (3458±24 BP, MAMS-32475)",3458,nan,Olalde et al. 2019,,,0,0,..,504.086547,fasta,11467G;12308G;12372A;150T;16192T;16270T;228A,11467;12308;12372;150;16192;16270;228,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Low VO2max response,Reported;Conflicting reports,+;nr,-;+;nr
I8136,I8136,Spain,,,Spain_EBA,,Spain_EBA,,37.7263,-2.5141,F,"Granada, Orce",,K1b1a1,n/a (female),-3216,-3150,"1534-1422 calBCE (3216±33 BP, Ua-39408)",3216,39408,Olalde et al. 2019,,,0,0,n/a (female),54.3,fasta,10398G;11467G;12308G;12372A;13967T;15257A;16093C;5913A;9055A,10398;11467;12308;12372;13967;15257;16093;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CYB;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;LHON;Cyclic Vomiting Syndrome;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;-,-;+
I8144,I8144,Spain,,,Spain_EBA,,Spain_EBA,,37.7263,-2.5141,F,"Granada, Orce",,U5b3f,n/a (female),-3426,-3358,"1876-1622 calBCE (3426±34 BP, Ua-39403)",3426,39403,Olalde et al. 2019,,,0,0,n/a (female),21,fasta,11467G;12308G;12372A;150T;16129A;16192T;16270T;228A,11467;12308;12372;150;16129;16192;16270;228,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Cyclic Vomiting Syndrome with Migraine;Melanoma patients;Low VO2max response,Reported;Conflicting reports,+;-;nr,-;+;nr
VAD001,VAD001,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,M,"La Rioja, Hervías, Valdescusa",,U5b1,..,-3400,-3330,"1872-1547 calBCE (3400±35 BP, Ua-36345)",3400,36345,Olalde et al. 2019,,,0,0,..,..,fasta,,,,,,,
VAD005,VAD005,Spain,,,Spain_EBA,,Spain_EBA,,42.44,-2.8867,M,"La Rioja, Hervías, Valdescusa",,J2b1a2,..,-3360,-3300,"1740-1539 calBCE (3360±30 BP, Beta-479535)",3360,nan,Olalde et al. 2019,,,0,0,..,..,fasta,,,,,,,
I7162,I7162,Spain,,,Spain_EBA_Africa,,Spain_EBA_Africa,,36.391401,-6.168503,F,"Andalusia, Cádiz, Chiclana de la Frontera, Loma del Puerco",,T2e,n/a (female),-3483,-3449,"1881-1744 calBCE (3483±17 BP) [R_combine: (3524±30 BP, CNA4237.1.1); (3465±20 BP, PSUAMS-4262)]",3483,nan,Olalde et al. 2019,,,0,0,n/a (female),27.5,fasta,11251G;150T;15928A;4216C;4917G,11251;150;15928;4216;4917,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Longevity / Cervical Carcinoma / HPV infection risk;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;+;-
I12171,I12171,Spain,,,Spain_EIA_Tartessian,,Spain_EIA_Tartessian,,37.51833,-5.97833,F,"Andalusia, Sevilla, Alcalá del Río, La Angorrilla",,J1c1b,n/a (female),-2520,-2480,"779-549 calBCE (2520±20 BP, PSUAMS-9549)",2520,nan,Patterson et al. 2021,,,0,0,n/a (female),35.599916,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;3394C;4216C;462T;489C,10398;11251;13708;185;228;295;3010;3394;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Diabetes / CPTdeficiency / high altitude adaptation;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Population-dependent,+;nr,-;nr;+
ElMiron,ElMiron_d,Spain,,,Spain_ElMiron,,Spain_ElMiron,,43.26,-3.45,F,El Miron,,U5b,n/a (female),-5460,-5380,"16898-16747 calBCE (15460±40 BP, MAMS-14585)",5460,nan,Fu et al. 2016,,,0,0,n/a (female),..,fasta,,,,,,,
I0409,I0409,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,F,Els Trocs,,J1c3,n/a (female),-6280,-6230,"5312-5212 calBCE (6280±25 BP, MAMS-16159)",6280,nan,Mathieson et al. 2015,,,0,0,n/a (female),521.130123,fasta,10398G;11251G;13708A;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I0410,I0410,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,M,Els Trocs,,T2c1d+152,R1b1a ,-6217,-6167,"5298-5057 calBCE (6217±25 BP, MAMS-16161)",6217,nan,Mathieson et al. 2015,,,0,0,..,353.211902,fasta,11251G;146C;15928A;4216C;4917G;6261A,11251;146;15928;4216;4917;6261,MT-ND4;MT-CR;MT-TT;MT-ND1;MT-ND2;MT-CO1,Reduced risk of PD;Absence of Endometriosis;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN;Prostate Cancer / LHON,Reported;Conflicting reports,nr;+,nr;-
I0412,I0412,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,M,Els Trocs,,N1a1a1,..,-6249,-6193,"5309-5073 calBCE (6249±28 BP, MAMS-16164)",6249,nan,Mathieson et al. 2015,,,0,0,..,831.404551,fasta,10398G;12705T;15043A;3336C;669C,10398;12705;15043;3336;669,MT-ND3;MT-CO1;MT-CYB;MT-ND1;MT-RNR1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Possible protective factor for normal tension glaucoma;MDD-associated;Carotid atherosclerosis risk;DEAF,Reported / lineage L & M marker / also hg IJK;Reported,+;NaN;-,-;NaN;+
I0413,I0413,Spain,,,Spain_EN,,Spain_EN,,42.5,0.5,F,Els Trocs,,V,n/a (female),-6234,-6178,"5304-5065 calBCE (6234±28 BP, MAMS-16166)",6234,nan,Mathieson et al. 2015,,,0,0,n/a (female),596.214738,fasta,,,,,,,
I1972,I1972,Spain,,,Spain_EN,,Spain_EN,,42.6282,-3.11649,F,"Burgos, El Prado de Pancorbo",,K1a4a1,n/a (female),-5880,-5820,"4836-4687 calBCE (5880±30 BP, Beta-366569)",5880,nan,Lipson et al. 2017,,,0,0,n/a (female),438,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2199,I2199,Spain,,,Spain_EN,,Spain_EN,,42.6282,-3.11649,F,"Burgos, El Prado de Pancorbo",,H1,n/a (female),-6170,-6110,"5214-5015 calBCE (6170±30 BP, Beta-438208)",6170,nan,Lipson et al. 2017,,,0,0,n/a (female),273,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
CB13,CB13_noUDG.SG,Spain,,,Spain_EN.SG,,Spain_EN.SG,,41.37,1.89,F,"Cova Bonica, Vallirana, Barcelona",,K1a2a,n/a (female),-6410,-6350,"5474-5318 calBCE (6410±30 BP, Beta-384724)",6410,nan,Olalde et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
I8215,I8215,Spain,,,Spain_Greek_oAegean,,Spain_Greek_oAegean,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,HV11,n/a (female),-2445,-2415,"746-415 calBCE (2445±15 BP, PSUAMS-8174)",2445,nan,Olalde et al. 2019,,,0,0,n/a (female),..,fasta,,,,,,,
I8209,I8209,Spain,,,Spain_Greek_oLocal,,Spain_Greek_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,U1a1a,..,-2455,-2415,"752-417 calBCE (2455±20 BP, PSUAMS-8221)",2455,nan,Olalde et al. 2019,,,0,0,..,..,fasta,11467G;12308G;12372A;16189C,11467;12308;12372;16189,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported,+,-;+
I8208,I8208,Spain,,,Spain_Hellenistic_oAegean,,Spain_Hellenistic_oAegean,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H33,..,-2220,-2180,"376-201 calBCE (2220±20 BP, PSUAMS-4277)",2220,nan,Olalde et al. 2019,,,0,0,..,..,fasta,,,,,,,
I8206,I8206,Spain,,,Spain_Hellenistic_oLocal,,Spain_Hellenistic_oLocal,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H7a1,..,-2130,-2100,"340-57 calBCE (2130±15 BP, PSUAMS-8173)",2130,nan,Olalde et al. 2019,,,0,0,..,..,fasta,,,,,,,
I8204,I8204,Spain,,,Spain_Hellenistic_oMixed,,Spain_Hellenistic_oMixed,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,H1e,n/a (female),-2155,-2125,"350-111 calBCE (2155±15 BP, PSUAMS-8172)",2155,nan,Olalde et al. 2019,,,0,0,n/a (female),..,fasta,,,,,,,
I3209,I3209,Spain,,,Spain_HG,,Spain_HG,,40.41819566,-0.11675,M,"Valencian Community, Castelló/Castellón, Ares del Maestre, Cingle del Mas Nou",,U5b1d1,..,-6980,-6930,"5978-5773 calBCE (6980±25 BP, PSUAMS-4414)",6980,nan,Olalde et al. 2019,,,0,0,..,4.466353,fasta,150T;16270T;12372A;11467G,150;16270;12372;11467,MT-CR;MT-ND5;MT-ND4,Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients;Altered brain pH / sCJD patients,Conflicting reports;Reported,+;nr,+;nr;-
I0843,I0843,Spain,,,Spain_HG_brother.I0585,,Spain_HG_brother.I0585,,42.911,-5.3778,M,"Castilla y León, León, La Brana-Arintero",,U5b2c1,..,-7030,-6930,"6015-5789 calBCE (7030±50 BP, Beta-226473)",7030,nan,Olalde et al. 2019,,,0,0,..,138,fasta,11467G;12308G;12372A;13637G;150T;16192T;16270T,11467;12308;12372;13637;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I8130,I8130,Spain,,,Spain_HG_lc,,Spain_HG_lc,,39.79,-1.033333,M,"Valencian Community, València/Valencia, Dos Aguas, Cueva de la Cocina",,U5b2b,..,-7135,-7085,"6064-5926 calBCE (7135±25 BP, PSUAMS-4429)",7135,nan,Olalde et al. 2019,,,0,0,..,15,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I12410,I12410,Spain,,,Spain_IA,,Spain_IA,,41.3616,1.6694,M,"Catalonia, Barcelona, Pacs del Penedès, Mas d'en Boixos-1",,H,..,-2350,-2290,"537-381 calBCE (2350±30 BP, Beta-495153)",2350,nan,Olalde et al. 2019,,,0,0,..,648.4,fasta,,,,,,,
I12641,I12641,Spain,,,Spain_IA,,Spain_IA,,41.5373,2.1329,M,"Barcelona, Can Roqueta-Can Revella",,HV0d,..,-2510,-2450,"786-541 calBCE (2510±30 BP, Beta-449093)",2510,nan,Olalde et al. 2019,,,0,0,..,62.06,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I12878,I12878,Spain,,,Spain_IA,,Spain_IA,,41.3616,1.6694,F,"Barcelona, Pacs del Penedès, Mas d'en Boixos-1",,H3,n/a (female),-2340,-2280,"516-364 calBCE (2340±30 BP, Beta-495155)",2340,nan,Olalde et al. 2019,,,0,0,n/a (female),74.15,fasta,,,,,,,
I12879,I12879,Spain,,,Spain_IA,,Spain_IA,,41.3324,1.5943,F,"Barcelona, Castellví de la Marca, Hort d'en Grimau",,HV0+195,n/a (female),-2390,-2330,"725-394 calBCE (2390±30 BP, Beta-495156)",2390,nan,Olalde et al. 2019,,,0,0,n/a (female),364.7,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I3323,I3323,Spain,,,Spain_IA,,Spain_IA,,42.006615,3.078667,M,"Girona, Ullastret, Puig de Sant Andreu",,X2b,..,-2215,-2175,"373-199 calBCE (2215±20 BP, PSUAMS-2158)",2215,nan,Olalde et al. 2019,,,0,0,..,424.543364,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I3758,I3758,Spain,,,Spain_IA_Celt,,Spain_IA_Celt,,42.565,-2.58635,F,"Basque Country, Araba/Álava, Laguardia, La Hoya",,U5b1+16189+@16192,n/a (female),-2215,-2175,"373-199 calBCE (2215±20 BP, PSUAMS-3466)",2215,nan,Olalde et al. 2019,,,0,0,n/a (female),34.461947,fasta,11467G;12308G;12372A;150T;16189C;16270T,11467;12308;12372;150;16189;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3759,I3759,Spain,,,Spain_IA_Celt,,Spain_IA_Celt,,42.565,-2.58635,M,"Basque Country, Araba/Álava, Laguardia, La Hoya",,H1,..,-2195,-2145,"361-173 calBCE (2195±25 BP, PSUAMS-2078)",2195,nan,Olalde et al. 2019,,,0,0,..,291,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12642,I12642,Spain,,,Spain_IA_lc,,Spain_IA_lc,,41.5373,2.1329,F,"Barcelona, Can Roqueta II",,H,n/a (female),-2400,-2340,"733-397 calBCE (2400±30 BP, Beta 463858)",2400,nan,Olalde et al. 2019,,,0,0,n/a (female),168,fasta,,,,,,,
I12643,I12643,Spain,,,Spain_IA_lc,,Spain_IA_lc,,41.5373,2.1329,F,"Barcelona, Can Roqueta II",,J2a1a1c,n/a (female),-2460,-2400,"758-416 calBCE (2460±30 BP, Beta 449091)",2460,nan,Olalde et al. 2019,,,0,0,n/a (female),46.63,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I3324,I3324,Spain,,,Spain_IA_o,,Spain_IA_o,,42.006615,3.078667,M,"Girona, Ullastret, Puig de Sant Andreu",,H1,..,-2190,-2150,"359-172 calBCE (2190±20 BP, PSUAMS-2159)",2190,nan,Olalde et al. 2019,,,0,0,..,577,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I12516,I12516,Spain,,,Spain_Islamic,,Spain_Islamic,,40.4703,0.4756,F,"Valencian Community, Castelló/Castellón, Vinaròs, Plaza Parroquial",,U5b2b2,n/a (female),-1030,-970,"899-1147 calCE (1030±30 BP, Beta-372984)",1030,nan,Olalde et al. 2019,,,0,0,n/a (female),147.1,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I2469,I2469_enhanced,Spain,,,Spain_LBA,,Spain_LBA,,42.57,-2.62,F,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,H3an,n/a (female),-2740,-2680,"971-813 calBCE (2740±30 BP, Beta-299308)",2740,nan,Patterson et al. 2021,,,0,0,n/a (female),..,fasta,,,,,,,
I2470,I2470_enhanced,Spain,,,Spain_MBA,,Spain_MBA,,42.57,-2.62,M,"Basque Country, Alava, El Sotillo",,J2a1a1,..,-3060,-3000,"1412-1227 calBCE (3060±30 BP, Beta-299307)",3060,nan,Patterson et al. 2021,,,0,0,..,1401.585069,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I2472,I2472,Spain,,,Spain_MBA,,Spain_MBA,,42.57,-2.62,M,"Basque Country, Araba/Álava, Laguardia, El Sotillo",,K1a+195,..,-3220,-3160,"1533-1427 calBCE (3220±30 BP, Beta-299309)",3220,nan,Olalde et al. 2019,,,0,0,..,321,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I3493,I3493,Spain,,,Spain_MBA,,Spain_MBA,,40.8586,-5.3518,F,"Salamanca, Aldeaseca de la Frontera, Tordillos",,H1,n/a (female),-3090,-3040,"1422-1281 calBCE (3090±25 BP, PSUAMS-2072)",3090,nan,Olalde et al. 2019,,,0,0,n/a (female),94.9,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I2470,I2470,Spain,,,Spain_MBA,,Spain_MBA,,42.57,-2.62,M,"Basque Country, Alava, El Sotillo",,J2a1a1,..,-3060,-3000,"1412-1227 calBCE (3060±30 BP, Beta-299307)",3060,nan,Olalde et al. 2019,,,0,0,..,85.429597,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I10895,I10895,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,M,"Catalonia, Girona, Sant Julià de Ramis",,H1ap1,..,-1140,-1080,"774-992 calCE (1140±30 BP, Beta-448953)",1140,nan,Olalde et al. 2019,,,0,0,..,304.2,fasta,16189C;3010A;5780A,16189;3010;5780,MT-CR;MT-RNR2;MT-TC,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;SNHL,Reported,+;-,-;+
I10851,I10851,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,F,"Catalonia, Girona, Sant Julià de Ramis",,H3,n/a (female),-1100,-1040,"887-1017 calCE (1100±30 BP, Beta-458691)",1100,nan,Olalde et al. 2019,,,0,0,n/a (female),71.19,fasta,16189C,16189,MT-CR,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients,Reported,+,-
I10852,I10852,Spain,,,Spain_Medieval,,Spain_Medieval,,42.0507,2.867,F,"Catalonia, Girona, Sant Julià de Ramis",,H6c,n/a (female),-1010,-950,"990-1154 calCE (1010±30 BP, Beta-458692)",1010,nan,Olalde et al. 2019,,,0,0,n/a (female),213.8,fasta,9804A,9804,MT-CO3,LHON / MS,Reported,+,+
I10854,I10854,Spain,,,Spain_Medieval_lc,,Spain_Medieval_lc,,42.0507,2.867,M,"Catalonia, Girona, Sant Julià de Ramis",,H1n+146,..,-1010,-950,"990-1154 calCE (1010±30 BP, Beta-448952)",1010,nan,Olalde et al. 2019,,,0,0,..,78.4,fasta,146C;3010A,146;3010,MT-CR;MT-RNR2,Absence of Endometriosis;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I0408,I0408,Spain,,,Spain_MLN,,Spain_MLN,,41.2522,-2.32622,F,La Mina,,U5b1+16189+@16192,n/a (female),-4970,-4910,"3895-3651 calBCE (4970±30 BP, Beta-316132)",4970,nan,Mathieson et al. 2015,,,0,0,n/a (female),513.621341,fasta,11467G;12308G;12372A;150T;16270T,11467;12308;12372;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7594,I7594,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,F,"Alicante, Alcoi, Llometes",,U5b2b,n/a (female),-4670,-4626,"3518-3371 calBCE (4670±22 BP, MAMS-16356)",4670,nan,Olalde et al. 2019,,,0,0,n/a (female),15.4,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7598,I7598,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Alicante, Alcoi, Llometes",,U5b3,..,-4710,-4666,"3622-3375 calBCE (4710±22 BP, MAMS-16346)",4710,nan,Olalde et al. 2019,,,0,0,..,31.2,fasta,11467G;12308G;12372A;150T;16192T;16270T,11467;12308;12372;150;16192;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I7601,I7601,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Alicante, Alcoi, Llometes",,X2b+226,..,-4810,-4766,"3644-3528 calBCE (4810±22 BP, MAMS-16354)",4810,nan,Olalde et al. 2019,,,0,0,..,21.1,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I7642,I7642,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,J2b1a,..,-4240,-4194,"2909-2706 calBCE (4240±23 BP, MAMS-16338)",4240,nan,Olalde et al. 2019,,,0,0,..,30.2,fasta,10398G;11251G;13708A;150T;15257A;15812A;295T;4216C;489C,10398;11251;13708;150;15257;15812;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports;Reported / Secondary,+;nr,-;nr;+
I7643,I7643,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,K1a1b1,..,-5040,-4974,"3952-3713 calBCE (5040±33 BP, MAMS-16344)",5040,nan,Olalde et al. 2019,,,0,0,..,27.2,fasta,10398G;11467G;114T;12308G;12372A;15924G;16093C;9055A,10398;11467;114;12308;12372;15924;16093;9055,MT-ND3;MT-ND4;MT-CR;MT-TL2;MT-ND5;MT-TT;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;BD-associated;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;LIMM;Cyclic Vomiting Syndrome;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;nr;-,-;+;nr
I7644,I7644,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,n/a (<2x),..,-4760,-4716,"3635-3386 calBCE (4760±22 BP, MAMS-16353)",4760,nan,Olalde et al. 2019,,,0,0,..,0.708,fasta,,,,,,,
I7645,I7645,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,HV0d,..,-5120,-5070,"3981-3804 calBCE (5120±25 BP, MAMS-16340)",5120,nan,Olalde et al. 2019,,,0,0,..,7.09,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I7646,I7646,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,F,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,H1e1c,n/a (female),-4880,-4824,"3711-3540 calBCE (4880±28 BP, MAMS-16339)",4880,nan,Olalde et al. 2019,,,0,0,n/a (female),21.2,fasta,3010A;3745A;5460A,3010;3745;5460,MT-RNR2;MT-ND1;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / high altitude variant;AD / PD / LHON,Reported;Reported / Population-dependent;Conflicting reports,+,-;+
I7647,I7647,Spain,,,Spain_MLN,,Spain_MLN,,38.7025,-0.48631,M,"Valencian Community, Alacant/Alicante, Alcoi, Les Llometes",,K1b1a,..,-5180,-5132,"4045-3955 calBCE (5180±24 BP, MAMS-16335)",5180,nan,Olalde et al. 2019,,,0,0,..,5.73,fasta,12308G;5913A;9055A;11467G;13967T;10398G;15257A;16093C,12308;5913;9055;11467;13967;10398;15257;16093,MT-TL2;MT-CO1;MT-ATP6;MT-ND4;MT-ND5;MT-ND3;MT-CYB;MT-CR,CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Prostate Cancer / hypertension;PD protective factor;Altered brain pH / sCJD patients;Possible LHON factor;PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;LHON;Cyclic Vomiting Syndrome,Reported;Reported / lineage L & M marker / also hg IJK;Conflicting reports,+;-,+;-
I8568,I8568,Spain,,,Spain_MLN,,Spain_MLN,,38.762271,-0.586981,F,"Valencian Community, València/Valencia, Bocairent, La Coveta Emparetà",,X2b+226,n/a (female),-4615,-4575,"3496-3355 calBCE (4615±20 BP, PSUAMS-4432)",4615,nan,Olalde et al. 2019,,,0,0,n/a (female),157,fasta,12705T;13708A;15927A;16189C;195C;8393T,12705;13708;15927;16189;195;8393,MT-CO1;MT-ND5;MT-TT;MT-CR;MT-ATP8,Possible protective factor for normal tension glaucoma;LHON / Increased MS risk / higher freq in PD-ADS;LHON / Multiple Sclerosis / DEAF1555 increased penetrance / CHD;Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients;BD-associated / melanoma pts;Reversible brain pseudoatrophy,Reported;Conflicting reports,NaN;+;-,NaN;+;-
I7595,I7595,Spain,,,Spain_MLN_1d.rel.I7594,,Spain_MLN_1d.rel.I7594,,38.7025,-0.48631,F,"Alicante, Alcoi, Llometes",,U5b2b5,n/a (female),-4670,-4624,"3518-3371 calBCE (4670±23 BP, MAMS-16332)",4670,nan,Olalde et al. 2019,,,0,0,n/a (female),22,fasta,11467G;12308G;12372A;12634G;13637G;150T;16270T,11467;12308;12372;12634;13637;150;16270,MT-ND4;MT-TL2;MT-ND5;MT-CR,Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Thyroid Cancer Cell Line;Possible LHON factor;Longevity / Cervical Carcinoma / HPV infection risk;Melanoma patients,Reported;Conflicting reports,+;nr,-;+;nr
I3273,I3273,Spain,,,Spain_MLN,,Spain_MLN,,42.57,-2.55,F,"Basque Country, Alava, La Chabola de la Hechicera",,J2a1a1,n/a (female),-4670,-4590,"3606-3363 calBCE (4670±40 BP, Beta-288935)",4670,nan,Lipson et al. 2017,,,0,0,n/a (female),..,fasta,10398G;11251G;13708A;150T;15257A;195C;295T;4216C;489C,10398;11251;13708;150;15257;195;295;4216;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-CYB;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Longevity / Cervical Carcinoma / HPV infection risk;LHON;BD-associated / melanoma pts;Low VO2max response;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I7160,I7160,Spain,,,Spain_MLN_lc,,Spain_MLN_lc,,36.445,-6.21,F,"Andalusia, Cádiz, San Fernando, Campo de Hockey",,T2c1d,n/a (female),-5140,-5070,"4042-3803 calBCE (5140±35 BP, CNA4579.1.1)",5140,nan,Olalde et al. 2019,,,0,0,n/a (female),2.17,fasta,146C;4917G;4216C;15928A;11251G;6261A,146;4917;4216;15928;11251;6261,MT-CR;MT-ND2;MT-ND1;MT-TT;MT-ND4;MT-CO1,Absence of Endometriosis;LHON / Insulin Resistance / AMD / NRTI-PN;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;Reduced risk of PD;Prostate Cancer / LHON,Reported;Conflicting reports,+;nr,-;nr
I3980,I3980,Spain,,,Spain_Roman_oAfrica,,Spain_Roman_oAfrica,,37.1775,-3.609166667,F,"Andalusia, Granada, Paseíllos universitarios-Fuentenueva",,H1e1c,n/a (female),-1520,-1480,"483-603 calCE (1520±20 BP, PSUAMS-2110)",1520,nan,Olalde et al. 2019,,,0,0,n/a (female),112,fasta,3010A;3745A;5460A,3010;3745;5460,MT-RNR2;MT-ND1;MT-ND2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / high altitude variant;AD / PD / LHON,Reported;Reported / Population-dependent;Conflicting reports,+,-;+
I3983,I3983,Spain,,,Spain_Roman_oAfrica,,Spain_Roman_oAfrica,,37.1775,-3.609166667,M,"Granada, Plaza Einstein",,H4a1c2,..,-1660,-1610,"261-531 calCE (1660±25 BP, PSUAMS-2081)",1660,nan,Olalde et al. 2019,,,0,0,..,76,fasta,14582G;7859A,14582;7859,MT-ND6;MT-CO2,LHON synergistic combo 14258A + 14582G;Progressive Encephalomyopathy,Reported: individually neutral variants causing LHON in combination;Reported,+,-
I8338,I8338,Spain,,,Spain_Roman_oAegean,,Spain_Roman_oAegean,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,HV0+195,n/a (female),-1900,-1860,"79-213 calCE (1900±20 BP, PSUAMS-8222)",1900,nan,Olalde et al. 2019,,,0,0,n/a (female),107,fasta,195C,195,MT-CR,BD-associated / melanoma pts,Reported,+,+
I8339,I8339,Spain,,,Spain_Roman_oLocal,,Spain_Roman_oLocal,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,K1a+195,n/a (female),-1870,-1840,"125-220 calCE (1870±15 BP, PSUAMS-8175)",1870,nan,Olalde et al. 2019,,,0,0,n/a (female),83.6,fasta,10398G;11467G;12308G;12372A;16093C;195C;9055A,10398;11467;12308;12372;16093;195;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Cyclic Vomiting Syndrome;BD-associated / melanoma pts;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+;-,-;+
I10866,I10866,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,F,"Girona, Empuries, necropolis Centre de Visitants",,K1b2a,n/a (female),-2005,-1975,"44 calBCE - 61 calCE (2005±15 BP, PSUAMS-5281)",2005,nan,Olalde et al. 2019,,,0,0,n/a (female),1053,fasta,10398G;11467G;12308G;12372A;146C;195C;5913A;9055A,10398;11467;12308;12372;146;195;5913;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-CR;MT-CO1;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;Absence of Endometriosis;BD-associated / melanoma pts;Prostate Cancer / hypertension;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I8216,I8216,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,H1,..,-1895,-1855,"80-215 calCE (1895±20 BP, PSUAMS-4212)",1895,nan,Olalde et al. 2019,,,0,0,..,..,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
I8343,I8343,Spain,,,Spain_Roman_oMixed,,Spain_Roman_oMixed,,42.1333,3.1083,M,"Girona, Empuries, necropolis Centre de Visitants",,J1c2c2,..,-1355,-1325,"647-676 calCE (1355±15 BP, PSUAMS-8223)",1355,nan,Olalde et al. 2019,,,0,0,..,171,fasta,10398G;11251G;13708A;146C;185A;228A;295T;3010A;4216C;462T;489C,10398;11251;13708;146;185;228;295;3010;4216;462;489,MT-ND3;MT-ND4;MT-ND5;MT-CR;MT-RNR2;MT-ND1,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Reduced risk of PD;LHON / Increased MS risk / higher freq in PD-ADS;Absence of Endometriosis;Low VO2max response;Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage,Reported / lineage L & M marker / also hg IJK;Reported;Conflicting reports,+;nr,-;nr;+
I3576,I3576,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,37.3244444,-4.005833333,M,"Granada, Montefrío, El Castillón",,T2c1a2,..,-1595,-1545,"421-542 calCE (1595±25 BP, PSUAMS-2117)",1595,nan,Olalde et al. 2019,,,0,0,..,260,fasta,11251G;15928A;4216C;4917G;6261A,11251;15928;4216;4917;6261,MT-ND4;MT-TT;MT-ND1;MT-ND2;MT-CO1,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN;Prostate Cancer / LHON,Reported;Conflicting reports,nr;+,nr;-
I3585,I3585,Spain,,,Spain_Visigoth_Granada,,Spain_Visigoth_Granada,,36.9572222,-4.12,M,"Granada, Ventas de Zafarraya",,H1,..,-1250,-1200,"675-876 calCE (1250±25 BP, PSUAMS-2074)",1250,nan,Olalde et al. 2019,,,0,0,..,400,fasta,3010A,3010,MT-RNR2,Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor,Reported,+,-
RISE207,RISE207_noUDG.SG,Sweden,,,Sweden_BA.SG,,Sweden_BA.SG,,55.997,14.104,M,Ängamöllan,,J1c8a1,..,-3130,-3076,"1495-1301 calBCE (3130±27 BP, OxA-29651)",3130,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE175,RISE175_noUDG.SG,Sweden,,,Sweden_BA.SG,,Sweden_BA.SG,,55.397,13.6,M,Abekås I,,T1a1,..,-3025,-2965,"1396-1131 calBCE (3025±30 BP, OxA-28998)",3025,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE210,RISE210_noUDG.SG,Sweden,,,Sweden_BA.SG,,Sweden_BA.SG,,55.997,14.104,F,Ängamöllan,,T2a1a,n/a (female),-3105,-3049,"1436-1286 calBCE (3105±28 BP, OxA-29654)",3105,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
RISE174,RISE174_noUDG.SG,Sweden,,,Sweden_IA.SG,,Sweden_IA.SG,,55.545,13.098,M,Oxie 7,,W1,..,-1521,-1445,"433-639 calCE (1521±38 BP, UBA-28275)",1521,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE179,RISE179_noUDG.SG,Sweden,,,Sweden_LN.SG,,Sweden_LN.SG,,55.397,13.6,M,Abekås I,,K1a3,..,-3556,-3500,"2015-1774 calBCE (3556±28 BP, OxA-29193)",3556,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
RISE97,RISE97_noUDG.SG,Sweden,,,Sweden_LN.SG,,Sweden_LN.SG,,55.557,13.059,F,Fredriksberg,,K2a5,n/a (female),-3590,-3532,"2030-1830 calBCE (3590±29 BP, OxA-28986)",3590,nan,Allentoft et al. 2015,,,0,0,n/a (female),..,fasta,,,,,,,
RISE98,RISE98_noUDG.SG,Sweden,,,Sweden_LN.SG,,Sweden_LN.SG,,55.381,13.445,M,L Beddinge 56,,K1b1a1,..,-3736,-3672,"2278-2032 calBCE (3736±32 BP, OxA-28987)",3736,nan,Allentoft et al. 2015,,,0,0,..,..,fasta,,,,,,,
Bichon,Bichon_noUDG.SG,Switzerland,,,Switzerland_Bichon.SG,,Switzerland_Bichon.SG,,47.09999847,6.869999886,M,Grotte du Bichon,,U5b1h,I2a,-1855,-1755,"11850-11579 calBCE (11855±50 BP, OxA-27763)",1855,nan,Jones et al. 2015,,,0,0,..,..,fasta,,,,,,,
MX298,MX298,Switzerland,,,Switzerland_EBA_2,,Switzerland_EBA_2,,47.45,9.292,M,Wartau,,X2b4,..,-3988,-3910,"2622-2349 calBCE (3988±39 BP, BE-8022.1.1)",3988,nan,Furtwangler et al. 2020,,,0,0,..,..,fasta,,,,,,,
Aes20,Aes20,Switzerland,,,Switzerland_LN,,Switzerland_LN,,47.465413,7.601691,M,Aesch,,K2b1a,..,-4269,-4221,"2917-2876 calBCE (4269±24 BP, BE-9188.1.1)",4269,nan,Furtwangler et al. 2020,,,0,0,..,..,fasta,,,,,,,
MX299,MX299,Switzerland,,,Switzerland_LN_contam_o,,Switzerland_LN_contam_o,,47.262067,7.659835,M,Oberbipp Horgen,,..,..,-4225,-4151,"2910-2674 calBCE (4225±37 BP, BE-6191.1.1)",4225,nan,Furtwangler et al. 2020,,,0,0,..,..,fasta,,,,,,,
I1584,I1584,Turkey,,,Turkey_C,,Turkey_C,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016,-4954,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,nan,Lazaridis et al. 2016,,,0,0,n/a (female),..,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I1584_noUDG,Turkey,,,Turkey_C,,Turkey_C,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barc�n",,K1a17,n/a (female),-5016,-4954,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,nan,Lazaridis et al. 2022,,,0,0,n/a (female),863.207798,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I2500_noUDG,Turkey,,,Turkey_C_dup.I1584_do.not.mergeI2500,,Turkey_C_dup.I1584_do.not.mergeI2500,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016,-4954,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,nan,Lazaridis et al. 2016,,,0,0,n/a (female),475,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I5395,Turkey,,,Turkey_C_dup.I1584_do.not.mergeI5395,,Turkey_C_dup.I1584_do.not.mergeI5395,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016,-4954,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,nan,Lazaridis et al. 2016,,,0,0,n/a (female),168,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I1584,I5432,Turkey,,,Turkey_C_dup.I1584_do.not.mergeI5432,,Turkey_C_dup.I1584_do.not.mergeI5432,,40.3,29.56,F,"Northwest Anatolia, Marmara, Barcın",,K1a17,n/a (female),-5016,-4954,"3946-3660 calBCE (5016±31 BP, OxA-32776)",5016,nan,Lazaridis et al. 2016,,,0,0,n/a (female),40,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2495,I2495,Turkey,,,Turkey_EBA,,Turkey_EBA,,37.91774,30.70839,M,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,H,..,-3925,-3855,"2560-2295 calBCE (3925±35 BP, Poz-81111)",3925,nan,Lazaridis et al. 2017,,,0,0,..,430.651458,fasta,,,,,,,
I2499,I2499,Turkey,,,Turkey_EBA,,Turkey_EBA,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,K1a2,n/a (female),-4040,-3970,"2836-2468 calBCE (4040±35 BP, Poz-82213)",4040,nan,Lazaridis et al. 2017,,,0,0,n/a (female),22.323375,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2683,I2683,Turkey,,,Turkey_EBA,,Turkey_EBA,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,T2b+152,n/a (female),-4015,-3955,"2621-2467 calBCE (4015±30 BP, PSUAMS-1988)",4015,nan,Lazaridis et al. 2017,,,0,0,n/a (female),583,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
I2495,I2495_noUDG,Turkey,,,Turkey_EBA_noUDG,,Turkey_EBA_noUDG,,37.91774,30.70839,M,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,H,..,-3925,-3855,"2560-2295 calBCE (3925±35 BP, Poz-81111)",3925,nan,Lazaridis et al. 2022,,,0,0,..,430.651458,fasta,,,,,,,
I2499,I2499_noUDG,Turkey,,,Turkey_EBA_noUDG,,Turkey_EBA_noUDG,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,K1a2,n/a (female),-4040,-3970,"2836-2468 calBCE (4040±35 BP, Poz-82213)",4040,nan,Lazaridis et al. 2022,,,0,0,n/a (female),22.323375,fasta,10398G;11467G;12308G;12372A;9055A,10398;11467;12308;12372;9055,MT-ND3;MT-ND4;MT-TL2;MT-ND5;MT-ATP6,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy;Altered brain pH / sCJD patients;CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD;PD protective factor,Reported / lineage L & M marker / also hg IJK;Reported,+,-;+
I2683,I2683_noUDG,Turkey,,,Turkey_EBA_noUDG,,Turkey_EBA_noUDG,,37.91774,30.70839,F,"Harmanören-Göndürle Höyük (Mediterranean, Isparta) ",,T2b+152,n/a (female),-4015,-3955,"2621-2467 calBCE (4015±30 BP, PSUAMS-1988)",4015,nan,Lazaridis et al. 2022,,,0,0,n/a (female),594.123785,fasta,11251G;15928A;4216C;4917G,11251;15928;4216;4917,MT-ND4;MT-TT;MT-ND1;MT-ND2,Reduced risk of PD;Multiple Sclerosis / idiopathic repeat miscarriage / AD protection;LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage;LHON / Insulin Resistance / AMD / NRTI-PN,Reported;Conflicting reports,nr;+,nr;-
Tep006,Tep006_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N_father.or.son.Tep004.SG,,Turkey_TepecikCiftlik_N_father.or.son.Tep004.SG,,38.172218,34.49387,M,Tepecik Ciftlik,,N1a1a1,..,-7280,-7220,"6223-6072 calBCE (7280±30 BP, Beta-410035)",7280,nan,Kilinc et al. 2016,,,0,0,..,..,fasta,,,,,,,
Tep002,Tep002_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N.SG,,Turkey_TepecikCiftlik_N.SG,,38.172218,34.49387,F,Tepecik Ciftlik,,K1a12a,n/a (female),-7710,-7650,"6636-6467 calBCE (7710±30 BP, Beta-410031)",7710,nan,Kilinc et al. 2016,,,0,0,n/a (female),..,fasta,,,,,,,
Tep003,Tep003_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N.SG,,Turkey_TepecikCiftlik_N.SG,,38.172218,34.49387,M,Tepecik Ciftlik,,N1b1a,..,-7630,-7570,"6570-6422 calBCE (7630±30 BP, Beta-410032)",7630,nan,Kilinc et al. 2016,,,0,0,..,..,fasta,,,,,,,
Tep004,Tep004_noUDG.WGC,Turkey,,,Turkey_TepecikCiftlik_N.SG,,Turkey_TepecikCiftlik_N.SG,,38.172218,34.49387,F,Tepecik Ciftlik,,N1a1a1,n/a (female),-7400,-7340,"6385-6102 calBCE (7400±30 BP, Beta-410033)",7400,nan,Kilinc et al. 2016,,,0,0,n/a (female),..,fasta,,,,,,,
ILK002,ILK002,Ukraine,,,Ukraine_EBA_GlobularAmphora,,Ukraine_EBA_GlobularAmphora,,49.55777778,27.68861111,M,Ilatka,,..,..,-4192,-4148,"2889-2675 calBCE (4192±22 BP, MAMS-30073)",4192,nan,Mathieson et al. 2018,,,0,0,..,..,fasta,,,,,,,
ILK001,ILK001,Ukraine,,,Ukraine_GlobularAmphora,,Ukraine_GlobularAmphora,,49.55777778,27.68861111,M,Ilatka,,..,..,-4221,-4177,"2900-2701 calBCE (4221±22 BP, MAMS-30072)",4221,nan,Mathieson et al. 2018,,,0,0,..,..,fasta,,,,,,,
ILK003,ILK003,Ukraine,,,Ukraine_GlobularAmphora,,Ukraine_GlobularAmphora,,49.55777778,27.68861111,F,Ilatka,,..,n/a (female),-4225,-4181,"2901-2703 calBCE (4225±22 BP, MAMS-30074)",4225,nan,Mathieson et al. 2018,,,0,0,n/a (female),..,fasta,,,,,,,
I1951,S1951.E1.L3_v54.1_addback,Iran,,,Iran_GanjDareh_N,,Iran_GanjDareh_N,,34.45,48.116,F,Ganj Dareh,,HV,..,-8800,-8700,"8198-7613 calBCE (8800±50 BP, Poz-81109)",8800,nan,Narasimhan et al. 2019,,,0,0,..,13.102963,fasta,,,,,,,
